Skip to main content
Semler Scientific, Inc. logo

Semler Scientific, Inc. — Investor Relations & Filings

Ticker · SMLR ISIN · US81684M1045 LEI · 549300ZHL16S29QTW485 US Professional, scientific and technical activities
Open in API
Filings indexed 864 across all filing types
Latest filing 2015-02-26 Director's Dealing
Country US United States of America
Listing US SMLR

About Semler Scientific, Inc.

https://www.semlerscientific.com/

Semler Scientific, Inc. is a company that develops, manufactures, and markets technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. Its primary focus is on products and services that support the early detection and treatment of chronic diseases. The company's flagship product is a patented, FDA-cleared system that provides a rapid, point-of-care test to aid in the diagnosis of peripheral artery disease (PAD). In addition to its healthcare technology operations, the company has adopted a corporate strategy to acquire and hold bitcoin as its primary treasury reserve asset.

Recent filings

Filing Released Lang Actions
OWNERSHIP DOCUMENT
Director's Dealing
2015-02-26 English
AMENDMENT NO. 1 TO SCHEDULE 13D
Major Shareholding Notification
2015-02-26 English
AMENDMENT NO. 1
Major Shareholding Notification
2015-02-17 English
AMENDMENT NO. 1 TO SCHEDULE 13G
Major Shareholding Notification
2015-02-13 English
FORM 10-K
Annual Report FY 2014
2015-02-13 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated February 6, 2015, by Semler Scientific, Inc. It announces the issuance of a press release regarding financial results for the fourth quarter and fiscal year ended December 31, 2014. The document itself does not contain the financial results but references an attached press release (Exhibit 99.1). The length of the document is 3356 characters, which is relatively short and primarily serves as an announcement of the earnings release rather than the earnings release itself. According to the rules, such a document is classified as an Earnings Release (ER) if it contains key highlights of financial results. However, since this is a Form 8-K announcing the press release and furnishing it as an exhibit, and the text states the information "shall not be deemed filed" except as expressly referenced, this is more consistent with a Regulatory Filing (RNS) that announces or furnishes the earnings release rather than the earnings release itself. Therefore, the best classification is Regulatory Filings (RNS) with high confidence.
2015-02-06 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.